Literature DB >> 7076761

Determination of penbutolol and its hydroxylated metabolite in biological fluids by reversed-phase high-performance liquid chromatography.

N Bernard, G Cuisinaud, J Sassard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7076761     DOI： 10.1016/s0378-4347(00)80454-5

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  7 in total

1.  Penbutolol: pharmacokinetics, effect on exercise tachycardia, and in vitro inhibition of radioligand binding.

Authors:  D Brockmeier; P Hajdù; W Henke; E Mutschler; D Palm; W Rupp; H Spahn; M T Verho; A Wellstein
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

2.  The comparative beta-adrenoceptor blocking effects of penbutolol, atenolol and sustained-release metoprolol in healthy volunteers.

Authors:  J C Mucklow; S Kuhn
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

3.  Pharmacokinetics of penbutolol and its metabolites in renal insufficiency.

Authors:  N Bernard; G Cuisinaud; N Pozet; P Y Zech; J Sassard
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

4.  Penbutolol: beta-adrenoceptor interaction and the time course of plasma concentrations explain its prolonged duration of action in man.

Authors:  A Wellstein; D Palm
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

5.  Comparison of the effects of penbutolol and propranolol on glomerular filtration rate in hypertensive patients with impaired renal function.

Authors:  J van der Meulen; E Reijn; G A Heidendal; P L Oe; A J Donker
Journal:  Br J Clin Pharmacol       Date:  1986-10       Impact factor: 4.335

6.  Penbutolol Pharmacokinetics: the influence of concomitant administration of cimetidine.

Authors:  H Spahn; W Kirch; P Hajdu; E Mutschler; E E Ohnhaus
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

7.  Haemodynamic dose-response effects of i.v. penbutolol in angina pectoris.

Authors:  B Silke; S P Verma; M Hussain; G I Nelson; R C Okoli; S H Taylor
Journal:  Br J Clin Pharmacol       Date:  1983-11       Impact factor: 4.335
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.